Lung Neoplasm — Trials

Lung Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,603 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 251–300 of 652 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07510594	A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC	not yet recruiting	Phase 2	48	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Apr 3, 2026	clinicaltrials
NCT07507188	Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients With EGFR-mutant, Locally Advanced or Metastatic/Recurrent Non-Small Cell Lung Cancer (INSTAR Study)(INSTAR)	not yet recruiting	Phase 2	80	Yonsei University